Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LRX712 intra-articular injections for cartilage regeneration in knee osteoarthritis
2019-002963-92Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) and cartilage defect comparing LRX712 arm with Placebo arm (2 arms). Primary endpoint: Change in cartilage volume in medial femoral condyle. Started Oct 2019; status: completed.
02
Drugs
LRX712
03
Conditions
knee osteoarthritis (OA)cartilage defect
Beyond the preview
Go deeper on 2019-002963-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002963-92.